— Know what they know.
Not Investment Advice
Also trades as: CLNNW (NASDAQ) · $vol 0M

CLNN NASDAQ

Clene Inc.
1W: -3.5% 1M: -0.2% 3M: -30.9% YTD: -28.1% 1Y: -40.5% 3Y: -60.7% 5Y: -97.1%
$4.08
+0.06 (+1.49%)
 
Weekly Expected Move ±14.7%
$3 $4 $4 $5 $5
NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 42 · $52.1M mcap · 10M float · 1.02% daily turnover · Short 25% of daily vol

Balance Sheet Trends

Total Assets
$18M -33.7% ▼
5Y CAGR: -23.3%
Total Liabilities
$36M -1.3% ▼
5Y CAGR: -12.1%
Shareholders Equity
-$18M -98.6% ▼
Cash & Investments
$5M -57.3% ▼
5Y CAGR: -38.6%
Total Debt
$22M +4.0% ▲
5Y CAGR: +38.0%
Net Debt
$16M +89.7% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$50M$18M$29M$12M$5M
Short-Term Investments$0$5M$6M$0$0
Cash & ST Investments$50M$23M$35M$12M$5M
Net Receivables$2M$3M$1M$391K$0
Inventory$41K$43K$37K$68K$37K
Other Current Assets$2M$3M$2M$137K$4M
Total Current Assets$55M$29M$39M$16M$9M
Property, Plant & Equip.$8M$15M$13M$11M$9M
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$58K$58K$0$58K$58K
Other Non-Current Assets$0$0$58K$0$0
Total Non-Current Assets$8M$15M$13M$11M$9M
Total Assets$63M$44M$52M$27M$18M
— Liabilities —
Accounts Payable$2M$3M$2M$1M$892K
Short-Term Debt$0$6M$20M$359K$5M
Deferred Revenue$0$0$0$3M$0
Other Current Liabilities$520K$0$2M$0$5M
Total Current Liabilities$6M$14M$25M$10M$11M
Long-Term Debt$19M$19M$7M$15M$14M
Other Non-Current Liab.$21M$3M$2M$6M$8M
Total Non-Current Liabilities$44M$27M$14M$26M$25M
Total Liabilities$50M$41M$39M$36M$36M
— Equity —
Common Stock$6K$7K$13K$1K$1K
Retained Earnings-$163M-$193M-$243M-$282M-$308M
Accumulated OCI$233K$203K$199K$71K$172K
Total Stockholders Equity$13M$3M$13M-$9M-$18M
Total Liabilities & Equity$63M$44M$52M$27M$18M
— Key Metrics —
Total Debt$24M$32M$32M$21M$22M
Net Debt-$26M$13M$3M$9M$16M
Total Investments$58K$5M$6M$58K$58K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms